ACOR

Acorda Therapeutics

Delisted

ACOR was delisted on the 11th of April, 2024.

175 hedge funds and large institutions have $899M invested in Acorda Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 57 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
175
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.01M
Puts
$40.8M
Net Calls
Net Calls Change

Top Buyers

1 +$13.5M
2 +$11.8M
3 +$6.17M
4
SM
Sabby Management
Florida
+$4.96M
5
Millennium Management
Millennium Management
New York
+$4.58M

Top Sellers

1 -$13M
2 -$10.3M
3 -$8.01M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$7.43M
5
Goldman Sachs
Goldman Sachs
New York
-$7.15M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$687K
102
$632K
103
$628K
104
$610K
105
$605K
106
$602K
107
$582K
108
$566K
109
$564K
110
$551K
111
$493K
112
$487K
113
$466K
114
$461K
115
$446K
116
$421K
117
$414K
118
$412K
119
$376K
120
$352K
121
$348K
122
$341K
123
$340K
124
$321K
125
$288K